Complexed PSA reduces unnecessary biopsies in the 2.6 4.0 ng/mL PSA range.

被引：0
|
作者：
Cheli, CD
Partin, AW
Djavan, B
Brawer, MK
机构：
[1] Bayer HealthCare LLC, Div Diagnost, Tarrytown, NY USA
[2] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[3] Univ Vienna, Vienna, Austria
[4] NW Prostate Inst, Seattle, WA USA
来源：
CLINICAL CHEMISTRY | 2003年 / 49卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A97 / A98
页数：2
相关论文
共 50 条
  • [1] Complexed PSA reduces unnecessary biopsies in the 2.6-4.0 NG/ML PSA range
    Brawer, MK
    Cheli, C
    Partin, AW
    Djavan, B
    JOURNAL OF UROLOGY, 2003, 169 (04): : 116 - 117
  • [2] Complexed prostate specific antigen (PSA) reduces unnecessary prostate biopsies in the 2.6-4.0 ng/mL range of total PSA
    Parsons, JK
    Brawer, MK
    Cheli, CD
    Partin, AW
    Djavan, R
    BJU INTERNATIONAL, 2004, 94 (01) : 47 - 50
  • [3] Should we biopsy men with PSA of 2.6-4.0 ng/mL?
    Zhu, H
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    JOURNAL OF UROLOGY, 2003, 169 (04): : 276 - 276
  • [4] Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL
    Socrates Castro, Hugo A.
    Iared, Wagner
    Mourao Santos, Jose Eduardo
    Solha, Raphael Sandes
    Shigueokal, David Carlos
    Ajzen, Sergio Aron
    INTERNATIONAL BRAZ J UROL, 2018, 44 (04): : 709 - 716
  • [5] ProPSA improves the detection of prostate cancer compared to % free PSA or complexed PSA in the 4-10 ng/ml range and especially in the 2-4 ng/ml PSA range
    Bartsch, G
    Harninger, W
    Klocker, H
    Mikolajczyk, SD
    Linton, HJ
    Evans, CL
    Amirkhan, A
    Rittenhouse, HG
    Catalona, WJ
    JOURNAL OF UROLOGY, 2003, 169 (04): : 426 - 426
  • [6] Robustness of free prostate specific antigen measurements to reduce unnecessary biopsies in the 2.6 to 4.0 ng./ml. range
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    JOURNAL OF UROLOGY, 2002, 168 (03): : 922 - 925
  • [7] Biopsy of men with PSA level of 2.6 to 4.0 ng/ml associated with favorable pathologic features and PSA progression rate: A preliminary analysis
    Zhu, H
    Roehl, KA
    Antenor, JAV
    Catalona, WJ
    UROLOGY, 2005, 66 (03) : 547 - 551
  • [8] Proenzyme PSA for the early detection of prostate cancer in the 2.5-4.0 ng/ml total PSA range: Preliminary analysis
    Sokoll, LJ
    Chan, DW
    Mikolajczyk, SD
    Rittenhouse, HG
    Evans, CL
    Linton, HJ
    Mangold, LA
    Mohr, P
    Bartsch, G
    Klocker, H
    Horninger, W
    Partin, AW
    UROLOGY, 2003, 61 (02) : 274 - 276
  • [9] Impact of age on complexed PSA levels in men with total PSA levels of up to 20 ng/mL
    Berger, AP
    Cheli, C
    Levine, R
    Klocker, H
    Bartsch, G
    Horninger, W
    UROLOGY, 2003, 62 (05) : 840 - 844
  • [10] Complexed PSA and complexed/total PSA ratio for early detection of prostate cancer in men with serum PSA 2-4 ng/mL.
    Cheli, CD
    Ferreri, LF
    Chan, DW
    Sokoll, L
    Yeung, KK
    Allard, WJ
    Partin, AW
    Brawer, MK
    CLINICAL CHEMISTRY, 2000, 46 (06) : A157 - A157
12345